Results 141 to 150 of about 595,493 (289)

Comparative cardiovascular risk of sulfonylureas with low‐ and high‐affinities for cardiac mitochondrial adenosine triphosphate‐sensitive potassium channels versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: A cohort study

Diabetes, Obesity and Metabolism, Volume 27, Issue 12, Page 7502-7513, December 2025.
Abstract Aims To individually evaluate the cardiovascular safety of low‐ and high‐affinity cardiac mitochondrial ATP‐sensitive potassium (mitoKATP) channel sulfonylureas by comparing each to dipeptidyl peptidase‐4 inhibitors (DPP‐4i), a generally cardiovascular‐neutral comparator, given prior evidence suggesting greater cardiovascular risk with high ...
Mei‐Hsiu Chen, Liang‐Yu Lin, Tung‐Ying Hung, Tzu‐Chieh Lin, Chia‐Yu Li, Tzu‐Han Lin, Yi‐Hsuan Chen, Jun‐Ting Liou, Meng‐Ting Wang   +8 more
wiley   +1 more source

Effect of the use of Clinical Pathway for Patients with Unstable Angina on Nursing Performance and Patient's Outcomes [PDF]

, 2018
Zienab Ibrahim
openalex   +1 more source

Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes

European Journal of Clinical Investigation, Volume 55, Issue 12, December 2025.
Despite universal healthcare in Switzerland, disparities in post‐acute coronary syndrome (ACS) care persist across educational levels. In a cohort of 6040 patients, those with the lowest education had more cardiovascular risk factors and were less likely to attend cardiac rehabilitation or receive cardiology follow‐up.
Maëlle Achard, Cédric Follonier, Evelyne Fournier, David Carballo, Mattia Branca, Dik Heg, David Nanchen, Lorenz Räber, Roland Klingenberg, Stephan Windecker, Thomas F. Lüscher, Christian M. Matter, Nicolas Rodondi, François Mach, Baris Gencer   +14 more
wiley   +1 more source

The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

New England Journal of Medicine, 1994
G. Liuzzo, L. Biasucci, J. Gallimore, R. Grillo, A. Rebuzzi, M. Pepys, A. Maseri   +6 more
semanticscholar   +1 more source

Colchicine and cardiovascular events: An updated meta‐analysis of published randomized controlled trials

Journal of Internal Medicine, Volume 298, Issue 6, Page 711-717, December 2025.
Abstract Background Colchicine shows promise in reducing cardiovascular risk, but a recent study raised the question whether this is really the case. We conducted a meta‐analysis of randomized controlled trials (RCTs) to assess its impact on cardiovascular outcomes in secondary prevention.
Sining Xie, Federica Galimberti, Elena Olmastroni, Alberico L. Catapano, Manuela Casula   +4 more
wiley   +1 more source

Upregulation of Fractalkine and Its Receptor, CX3CR1, is Associated With Coronary Plaque Rupture in Patients With Unstable Angina Pectoris

, 2010
Hideyuki Ikejima, Toshio Imanishi, Hiroto Tsujioka, Manabu Kashiwagi, Akio Kuroi, Takashi Tanimoto, Hironori Kitabata, Kohei Ishibashi, Kenichi Komukai, Tatsuya Takeshita, Takashi Akasaka   +10 more
openalex   +2 more sources

Platelet inhibitors may playa role in treating unstable angina [PDF]

, 1997

openalex   +1 more source

Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.

Cochrane Database of Systematic Reviews, 2016
J. Fanning, Jonathan Nyong, I. Scott, C. Aroney, D. Walters   +4 more
semanticscholar   +1 more source

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

Annals of Clinical and Translational Neurology, Volume 12, Issue 11, Page 2349-2357, November 2025.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang, Shenglan Li, Liang Wang, Qianxue Chen, Weiguo Hu, Ting Lei, Ying Mao, Jing Zhang, Xiaojun Xiang, Qiming Wang, Zhengwen He, Tao Sun, Yulei Wang, Mengqian Huang, Rong Zhang, Feng Chen, Wenbin Li   +16 more
wiley   +1 more source

Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry

ACR Open Rheumatology, Volume 7, Issue 11, November 2025.
Objective We performed a real‐world characterization of patients with rheumatoid arthritis (RA) who initiate a JAK inhibitor (JAKi) and switch to a subsequent therapy and examination of factors associated with the use of another JAKi/therapy with another mechanism of action (MoA).
Joshua F. Baker, Kristi V. Mizelle, Wassim Saikali, Page C. Moore, Hyung‐Joo Kang, David Gruben, Ahmed Shelbaya, Lori Stockert, Jacqueline O'Brien   +8 more
wiley   +1 more source